37 research outputs found

    STEREOFUNCTIONAL FEATURES OF MOTHER-PLACENTA-FETUS SYSTEM IN OPTIMIZATION OF COMPLEX TREATMENT OF THREATENING PRETERM LABOR

    Get PDF
    Purpose: improving the efficiency of complex treatment of threatened abortion.Materials and Methods: The study involved 299 primigravidas. The I clinical group consisted of 78 women with threatened miscarriage receiving combination therapy (standard medication and acupuncture). The II clinical group consisted of 76 women receiving combined medication and acupuncture to our improved method. In the III clinical group - 71 women with threatened miscarriage, which received only standard medical therapy. In the IV (control group) there were 74 pregnant women with physiological pregnancy.Results: It has been proven that the lateral stimulation of biologically active points of acupuncture taking into account the factor of placental laterality in the utero-placental-fetal complex initiate functional processes accompanied by an increase right asymmetry of utero-placental blood flow and uterine activity, and improvement of the fetus condition.Summary: We proved that in unilateral acupuncture impact to the placenta, processes of functional symmetry in the utero-placental-fetal complex in women with threatened termination of pregnancy are replaced by functional asymmetry of processes that improve the condition of the fetu

    ΠŸΠ΅Ρ€ΡΠΎΠ½ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹ΠΉ ΡƒΡ‡Π΅Ρ‚ Π·Π°Ρ‚Ρ€Π°Ρ‚ Π² управлСнчСском ΡƒΡ‡Π΅Ρ‚Π΅ мСдицинских ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΉ

    Get PDF
    In the modern economic conditions, the rational planning of costs and the complex process optimization are essential requirements to all organizations. Knowledge of costs is needed to correctly assess the economic performance of an organization. Competent and timely correction of tariffs for the obligatory medical insurance and rationalization of the requested financing of the medical organization depends on this assessment. In the present study, we analyze various methods of personalized cost accounting: the ratio of costs to charges (RCC); relative value unit (RVU); time-driven activity-based costing (TDABC), and the possibility of their adaptation to the specific needs of medical organizations. The personalized cost accounting incorporated into a medical information system allows for controlling, planning and carrying out a close internal management of financial activity. This function helps decision-makers: control the use of funds for medical care provision; increase the efficiency of management decisions; justify the prices of paid medical services; define the deficit and surplus work units; analyze the treatment cost for each patient, considering the diagnosis, method of treatment, age and other classification signs, including the reference to specialized departments; reduce the unnecessary β€œpaper” work load on the medical personnel; model the future needs of the organization in accordance with the planned changes in the hospitalization policy; optimize, control and plan the budget with regard to the established standards of financial expenses. Implementation of this approach is expected to increase the work efficiency in most medical organizations and the entire healthcare system.Π’ соврСмСнных экономичСских условиях Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½ΠΎΠΉ Ρ‡Π΅Ρ€Ρ‚ΠΎΠΉ для всСх ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΉ являСтся Ρ€Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ΅ ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ расходов ΠΈ комплСксная оптимизация процСссов. Π˜Π·ΡƒΡ‡Π΅Π½ΠΈΠ΅ Π·Π°Ρ‚Ρ€Π°Ρ‚ позволяСт Π²Ρ‹Ρ€Π°Π±ΠΎΡ‚Π°Ρ‚ΡŒ ΠΏΡ€Π°Π²ΠΈΠ»ΡŒΠ½ΡƒΡŽ ΠΎΡ†Π΅Π½ΠΊΡƒ уровня экономичСских ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ. ΠžΡ‚ Π΄Π°Π½Π½ΠΎΠΉ ΠΎΡ†Π΅Π½ΠΊΠΈ зависит грамотная ΠΈ своСврСмСнная ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ‚ΠΈΡ€ΠΎΠ²ΠΊΠ° Ρ‚Π°Ρ€ΠΈΡ„ΠΎΠ² ΠΎΠ±ΡΠ·Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ мСдицинского страхования ΠΈ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΠΎΡΡ‚ΡŒ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΠ³ΠΎ финансирования мСдицинской ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ. Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ приводится Π°Π½Π°Π»ΠΈΠ· Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² пСрсонифицированного ΡƒΡ‡Π΅Ρ‚Π° Π·Π°Ρ‚Ρ€Π°Ρ‚: ΠΌΠ΅Ρ‚ΠΎΠ΄Π° ΡΠΎΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΡ Π·Π°Ρ‚Ρ€Π°Ρ‚ ΠΊ ΠΏΡ€ΠΈΠ±Ρ‹Π»ΠΈ, ΠΌΠ΅Ρ‚ΠΎΠ΄Π° Π΅Π΄ΠΈΠ½ΠΈΡ†Ρ‹ ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ стоимости, систСма ΡƒΡ‡Π΅Ρ‚Π° Π·Π°Ρ‚Ρ€Π°Ρ‚ ΠΏΠΎ Π²ΠΈΠ΄Π°ΠΌ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ ΠΈ Π΅Π΅ ΠΌΠΎΠ΄ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ Time-driven ABC (TDABS), Π° Ρ‚Π°ΠΊΠΆΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ ΠΈΡ… Π°Π΄Π°ΠΏΡ‚Π°Ρ†ΠΈΠΈ для Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… Ρ†Π΅Π»Π΅ΠΉ мСдицинских ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΉ. БистСма пСрсонифицированного ΡƒΡ‡Π΅Ρ‚Π° Π·Π°Ρ‚Ρ€Π°Ρ‚, Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Π½Π°Ρ Π² ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΡƒΡŽ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΎΠ½Π½ΡƒΡŽ систСму, позволяСт ΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎ ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ, ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ ΠΈ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΡ‚ΡŒ Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½ΠΈΠΉ финансовый ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ. Π­Ρ‚Π° функция ΠΏΠΎΠΌΠΎΠ³Π°Π΅Ρ‚ Π»ΠΈΡ†Π°ΠΌ, ΠΏΡ€ΠΈΠ½ΠΈΠΌΠ°ΡŽΡ‰ΠΈΠΌ Ρ€Π΅ΡˆΠ΅Π½ΠΈΡ Π² мСдицинской ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ, Π² Ρ€Π΅ΡˆΠ΅Π½ΠΈΠΈ ΡΠ»Π΅Π΄ΡƒΡŽΡ‰ΠΈΡ… Π·Π°Π΄Π°Ρ‡: ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ использования срСдств Π½Π° ΠΎΠΊΠ°Π·Π°Π½ΠΈΠ΅ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ; усилСниС дСйствСнности ΠΈ опСративности управлСнчСских Ρ€Π΅ΡˆΠ΅Π½ΠΈΠΉ; обоснованиС Ρ†Π΅Π½Ρ‹ ΠΏΠ»Π°Ρ‚Π½Ρ‹Ρ… мСдицинских услуг; ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π΄Π΅Ρ„ΠΈΡ†ΠΈΡ‚Π½Ρ‹Ρ… ΠΈ ΠΏΡ€ΠΎΡ„ΠΈΡ†ΠΈΡ‚Π½Ρ‹Ρ… ΠΎΡ‚Π΄Π΅Π»Π΅Π½ΠΈΠΉ; Π°Π½Π°Π»ΠΈΠ· Π΄Π°Π½Π½Ρ‹Ρ… ΠΎ стоимости случая лСчСния ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π°, ΠΌΠ΅Ρ‚ΠΎΠ΄Π° лСчСния, возраста ΠΈ Π΄Ρ€ΡƒΠ³ΠΈΡ… классификационных ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠΎΠ², Π² Ρ‚.Ρ‡. Π² Ρ€Π°Π·Ρ€Π΅Π·Π΅ ΠΏΡ€ΠΎΡ„ΠΈΠ»ΡŒΠ½Ρ‹Ρ… ΠΎΡ‚Π΄Π΅Π»Π΅Π½ΠΈΠΉ; сниТСниС Β«Π±ΡƒΠΌΠ°ΠΆΠ½ΠΎΠΉΒ» Π½Π°Π³Ρ€ΡƒΠ·ΠΊΠΈ Π½Π° мСдицинский пСрсонал; ΠΌΠΎΠ΄Π΅Π»ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡƒΠ΄ΡƒΡ‰ΠΈΡ… потрСбностСй ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ Π² соотвСтствии с ΠΏΠ»Π°Π½ΠΈΡ€ΡƒΠ΅ΠΌΡ‹ΠΌΠΈ измСнСниями структуры госпитализации; оптимизация расходов, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ ΠΈ ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ установлСнных Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²ΠΎΠ² финансовых Π·Π°Ρ‚Ρ€Π°Ρ‚. РСализация Π΄Π°Π½Π½ΠΎΠ³ΠΎ процСсса являСтся Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Ρ‹ΠΌ ΠΈ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΡ‹ΠΌ инструмСнтом ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ эффСктивности Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ, ΠΊΠ°ΠΊ самой мСдицинской ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ, Ρ‚Π°ΠΊ ΠΈ всСй систСмы здравоохранСния Π² Ρ†Π΅Π»ΠΎΠΌ

    Seasonal periodicity of melatonin exchange and hormonal status of pregnant women in dependence on fetus sex

    Get PDF
    Objective: to study melatonin metabolism and hormonal status of pregnant women in different seasons of the year, depending on the sex of the fetus. Materials and methods: 538 women were examined at the time of physiological gestation of 37-40 weeks. The first group β€” 286 pregnant women with female fetuses and the second group β€” 254 pregnant with male fetuses. Estimation of the hormonal status included the determination of the level of cortisol, estradiol, adrenocorticotropic hormone, progesterone, testosterone in the blood and melatonin in the urine of pregnant women. Results: the level of 6-sulphatoxymelatonin in the morning urine, regardless of the sex of the fetus, was higher in the seasons of the year with the predominance of the dark time of the day. Absolute levels of 6-sulphatoxymelatonin in urine in all women in 37-40 weeks of gestation were the lowest in the light-saturated summer and spring months of the year, while in the winter period its parameters were maximal. Melatonin production was statistically significantly higher in pregnant women with female fetuses during the fall and winter periods of the year. Regardless of the time of the year, in pregnant women with female fetuses, the absolute levels of estradiol and progesterone were higher than in the case of the male fetus. The highest values in the case of the female fetus were noted in the spring. Testosterone production was significantly higher in pregnant women with male fetuses mainly in the spring season. Stress resistance of pregnant women was higher in the summer months. Depending on the β€œsex of the fetus” factor, stress hormones in the summer had the highest values in pregnant women with male fetuses. Conclusions: the sex of the fetus is a significant factor affecting the seasonal variability of melatonin production, sexual and stress hormones in pregnant women due to the formation of the specificity of the systemic signaling between the maternal and the fetal organism in the dynamics of pregnancy

    THE EFFECT OF LIGHT DEPRIVATION ON FUNCTIONAL PROCESSES IN THE SYSTEM β€œMOTHER – PLACENTA – FETUS” IN CASE OF THREATENING PRETERM BIRTH AND ITS CLINICAL SIGNIFICANCE

    Get PDF
    Objective: to study the nature of uterine contractile activity, hormonal status, melatonin metabolism, blood flow in the uterine and fetal vessels, and the state of the fetus wellbeing before and after standard drug treatment and combination therapy involving the additional use of light deprivation. Materials and methods: a total of 547 women with threatening preterm birth were examined at 28 – 35 weeks of pregnancy. Among these, 198 pregnant women received standard therapy and 196 women received combined treatment, medical along with light deprivation. The control group consisted of 153 women with physiological pregnancy. We used cardiotocography to study the contractile activity of the uterus and the fetal cardiac rhythm, enzyme-linked immunosorbent assay methods to study the expression of hormones (ACTH, cortisol, progesterone, estriol, placental lactogen) in the blood and 6-sulfatoxymelatonin in the urine of pregnant women. Results: threatening preterm labor is accompanied by an increase in the level of generalized (bilateral) uterine activity, a decrease in the level of melatonin and an increase in the level of stress hormones. After using standard drug therapy, there is a suppression of any form of uterine activity, which leads to a deterioration of the fetus state in 30,2% of women, while combined therapy increases the level of melatonin, decreases the activity of stress-liberating subsystems of the mother’s body, and increases the level of right-sided uterine contractions that contribute to maintaining functional activity of the uteroplacental β€œpump”, contributing to the prevention of fetal distress. Conclusions: theΒ studies indicate an improvement in the therapeutic effect with using light deprivation, as an additional method for tocolysis in women with the threat of premature birth

    Daily periodicity of labor in pregnant women in physiological and complicated pregnancy depending on the sex of the fetus

    Get PDF
    Objective: the study aimed to reveal the daily periodicity of labor, the nature of melatonin metabolism, and the outcome of childbirth in women with a physiological and complicated pregnancy, depending on the sex of the fetus.Materials and methods: to study the chronophysiological characteristics of birth outcomes depending on fetal sex, 1 980 birth histories and stories of newborns were analyzed. The neonates were born between January 1 and December 31, 2016, in a maternity ward of the Federal State Budgetary Educational Institution of Higher Education β€œRostGMU” of the Ministry of Health of Russia. Melatonin production was identified by the level of urinary excretion of 6-sulfatoxymelatonin (6-SM) (its main metabolite) examining the morning portion of the urine of women by the ELISA method (at 8 am 3 ml of urine were collected in Eppendorf tube).Results: it was revealed that fetal sex modulated the activity of the central regulatory mechanisms responsible for the daily period functional processes in the female body and the initiation of labor. The largest number of spontaneous births by male fetuses occurred in the early evening before midnight when daily illumination was decreased, while the birth of girls was observed more often in the period from midnight to early morning. At the same time, mothers of boys had lower production of melatonin compared to that of girls’ mothers.Conclusions. The peculiarities of labor and birth complications associated with the sex of the fetus were identified

    ΠœΠ•Π’ΠžΠ”ΠžΠ›ΠžΠ“Π˜Π― ΠžΠ¦Π•ΠΠšΠ˜ Π­Π€Π€Π•ΠšΠ’Π˜Π’ΠΠžΠ‘Π’Π˜ Π˜Π‘ΠŸΠžΠ›Π¬Π—ΠžΠ’ΠΠΠ˜Π― ΠšΠžΠ•Π§ΠΠžΠ“Πž Π€ΠžΠΠ”Π ΠœΠ•Π”Π˜Π¦Π˜ΠΠ‘ΠšΠ˜Π₯ ΠžΠ Π“ΠΠΠ˜Π—ΠΠ¦Π˜Π™

    Get PDF
    Since recently, a number of normative legal acts aimed at increasing the salaries of medical professionals in the Russian Federation have been implemented. As these decisions are not supported by increasing the financial bases of medical organizations, those institutions may develop the accounts payable status. Under these conditions, the efficient usage of hospital beds may bring a financial relief to these medical institutions. The present study addresses the assessment of bed usage and suggests a well-rationalized set of methods to evaluate and characterize the bed usage efficiency. The main indicators of this efficiency are: the number of beds, the bed turnover, the number of hospitalized patients, the average length of hospital stay per patient per year, and the average bed occupancy per year. In this study, we analyze the available data on the hospital bed usage taken from the annual statistical information published by the Ministry of Health of the Russian Federation. Using the method of chain substitutions we have found ways to improve the quality of medical services and reduce economic losses in medical organizations. Our results recommend implementing periodical analysis of the hospital bed usage both in general and in specialized clinics. The results also suggest mobilizing more reserves to increase the performance of hospital bed usage, mainly by increasing the bed occupancy in specialized round-the-clock hospitals. It is recommended to conduct a comparative analysis of the planned vs factual bed usage, to restructure the hospital setting with a possible change in the number of specialized beds, to optimize the routing of patients when providing primary medical care, as well as routing the patients when providing emergency service including emergency specialized medical care.Основной ΠΏΡ€ΠΈΡ‡ΠΈΠ½ΠΎΠΉ для Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΎΡ†Π΅Π½ΠΊΠΈ эффСктивности использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π° стала Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ выполнСния мСдицинскими организациями ряда Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΏΡ€Π°Π²ΠΎΠ²Ρ‹Ρ… Π°ΠΊΡ‚ΠΎΠ², Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½Ρ‹Ρ… Π½Π° ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ Π·Π°Ρ€Π°Π±ΠΎΡ‚Π½ΠΎΠΉ ΠΏΠ»Π°Ρ‚Ρ‹ сотрудникам ΡƒΡ‡Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ Π±ΡŽΠ΄ΠΆΠ΅Ρ‚Π½ΠΎΠΉ сфСры, Π² условиях ΠΏΡ€Π΅ΠΆΠ½Π΅Π³ΠΎ уровня финансирования, Ρ‡Ρ‚ΠΎ способствуСт Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΡŽ ΠΈ росту крСдиторской задолТСнности ΡƒΡ‡Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ. Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ рассмотрСны мСтодологичСскиС аспСкты ΠΎΡ†Π΅Π½ΠΊΠΈ использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π° мСдицинских ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΉ, выявлСна обоснованная ΡΠΎΠ²ΠΎΠΊΡƒΠΏΠ½ΠΎΡΡ‚ΡŒ ΠΏΡ€ΠΈΠ΅ΠΌΠΎΠ² ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² структуры ΠΎΡ†Π΅Π½ΠΎΡ‡Π½ΠΎΠΉ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ. ΠžΡΠ½ΠΎΠ²Π½Ρ‹ΠΌΠΈ показатСлями эффСктивности использования ΠΊΠΎΠ΅ΠΊ ΡΠ²Π»ΡΡŽΡ‚ΡΡ: количСство ΠΊΠΎΠ΅ΠΊ, ΠΎΠ±ΠΎΡ€ΠΎΡ‚ ΠΊΠΎΠΉΠΊΠΈ, количСство госпитализированных Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…, срСдняя Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ прСбывания ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° Π½Π° ΠΊΠΎΠΉΠΊΠ΅ Π² Π³ΠΎΠ΄Ρƒ (Π² днях), срСдняя Π·Π°Π½ΡΡ‚ΠΎΡΡ‚ΡŒ ΠΊΠΎΠΉΠΊΠΈ Π² Π³ΠΎΠ΄Ρƒ (Π² днях), срСднСС врСмя простоя ΠΊΠΎΠΉΠΊΠΈ. Π‘ Ρ†Π΅Π»ΡŒΡŽ ΠΎΡ†Π΅Π½ΠΊΠΈ возмоТностСй ΠΌΠ΅Ρ‚ΠΎΠ΄Π° ΠΎΡ†Π΅Π½ΠΊΠΈ эффСктивности использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π° Π² ΡΡ‚Π°Ρ‚ΡŒΠ΅ ΠΏΡ€ΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½Ρ‹ расчСты ΠΈ сравнСния Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² ΠΏΠΎ основным показатСлям эффСктивности использования ΠΊΠΎΠ΅ΠΊ Π½Π° основС ΠΎΡ‚ΠΊΡ€Ρ‹Ρ‚Ρ‹Ρ… Π΄Π°Π½Π½Ρ‹Ρ… (СТСгодная статистичСская информация, публикуСмая ΠœΠΈΠ½Π·Π΄Ρ€Π°Π²ΠΎΠΌ Π Π€). На основании ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π° ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ Ρ†Π΅ΠΏΠ½Ρ‹Ρ… подстановок Π² цСлях ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡ качСства мСдицинского обслуТивания ΠΈ сниТСния экономичСских ΠΏΠΎΡ‚Π΅Ρ€ΡŒ Π² мСдицинских организациях рСкомСндуСтся ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΡ‚ΡŒ Π°Π½Π°Π»ΠΈΠ· ΠΈ ΠΎΡ†Π΅Π½ΠΊΡƒ эффСктивности использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π° ΠΊΠ°ΠΊ Π² Ρ†Π΅Π»ΠΎΠΌ, Ρ‚Π°ΠΊ ΠΈ ΠΏΠΎ ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹ΠΌ профилям, ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Ρ‚ΡŒ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Ρ€Π΅Π·Π΅Ρ€Π²Ρ‹ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ интСнсивности использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π°, Π³Π»Π°Π²Π½Ρ‹ΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, Π·Π° счСт ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ срСднСй занятости ΠΊΠΎΠ΅ΠΊ ΠΏΠΎ ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹ΠΌ профилям круглосуточных ΠΊΠΎΠ΅ΠΊ стационара, ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΡ‚ΡŒ ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠ»Π°Π½ΠΎΠ²Ρ‹Ρ… ΠΈ фактичСских ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ использования ΠΊΠΎΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ„ΠΎΠ½Π΄Π°, ΡƒΠ΄Π΅Π»ΡΡ‚ΡŒ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ структурной пСрСстройкС стационара с Π²ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹ΠΌ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ количСства ΠΏΡ€ΠΎΡ„ΠΈΠ»ΡŒΠ½Ρ‹Ρ… ΠΊΠΎΠ΅ΠΊ, ΡƒΠ΄Π΅Π»ΡΡ‚ΡŒ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΌΠ°Ρ€ΡˆΡ€ΡƒΡ‚ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΏΡ€ΠΈ ΠΎΠΊΠ°Π·Π°Π½ΠΈΠΈ ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΠΊΠΎ-санитарной ΠΏΠΎΠΌΠΎΡ‰ΠΈ, ΡƒΠ΄Π΅Π»ΡΡ‚ΡŒ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΌΠ°Ρ€ΡˆΡ€ΡƒΡ‚ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΈ ΠΎΠΊΠ°Π·Π°Π½ΠΈΠΈ скорой, Π² Ρ‚ΠΎΠΌ числС скорой спСциализированной, мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ

    ΠžΠ±Π·ΠΎΡ€ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½ΠΎΠ³ΠΎ ΠΎΠΏΡ‹Ρ‚Π° финансирования ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Ρ… мСдицинских Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ

    Get PDF
    The article presents a review of the foreign approaches to the mechanisms of financing of medical help and innovative medical technologies with the description of the implemented financial mechanisms of stimulation of innovations in foreign systems of public healthcare. Since the system of payment for diagnosis-related groups (DRG) does not contribute to the implementation of innovations in the medical practice, the majority of countries apply additional mechanisms of financing of innovative technologies in public healthcare such as single and additional payments, and target financing that was initially not associated with a DRG model.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ прСдставлСн ΠΎΠ±Π·ΠΎΡ€ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… ΠΏΠΎΠ΄Ρ…ΠΎΠ΄ΠΎΠ² ΠΊ ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠ°ΠΌ финансирования мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΈ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Ρ… мСдицинских Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ, с описаниСм ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Ρ… финансовых ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠΎΠ² стимулирования ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΉ Π² Π·Π΄Ρ€Π°Π²ΠΎΠΎΡ…Ρ€Π°Π½Π΅Π½ΠΈΠΈ Π·Π° Ρ€ΡƒΠ±Π΅ΠΆΠΎΠΌ. Π’ связи с Ρ‚Π΅ΠΌ, Ρ‡Ρ‚ΠΎ ΠΎΠΏΠ»Π°Ρ‚Π° ΠΏΠΎ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-статистичСским Π³Ρ€ΡƒΠΏΠΏΠ°ΠΌ (ΠšΠ‘Π“) Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Π½Π΅ способствуСт Π²Π½Π΅Π΄Ρ€Π΅Π½ΠΈΡŽ ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΉ Π² ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΡƒΡŽ ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΡƒ, Π±ΠΎΠ»ΡŒΡˆΠΈΠ½ΡΡ‚Π²ΠΎ стран ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡŽΡ‚ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΡ‹ финансирования ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Ρ… Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ Π² Π·Π΄Ρ€Π°Π²ΠΎΠΎΡ…Ρ€Π°Π½Π΅Π½ΠΈΠΈ, Ρ‚Π°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹Π΅ ΠΈ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ ΠΏΠ»Π°Ρ‚Π΅ΠΆΠΈ, Ρ†Π΅Π»Π΅Π²ΠΎΠ΅ финансированиС, ΠΈΠ·Π½Π°Ρ‡Π°Π»ΡŒΠ½ΠΎ Π½ΠΈΠΊΠ°ΠΊ Π½Π΅ связанныС с модСлью ΠšΠ‘Π“

    Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Spinal muscular atrophy (SMA type I, II and III) is an autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron gene (<it>SMN1</it>). <it>SMN2 </it>is a centromeric copy gene that has been characterized as a major modifier of SMA severity. SMA type I patients have one or two <it>SMN2 </it>copies while most SMA type II patients carry three <it>SMN2 </it>copies and SMA III patients have three or four <it>SMN2 </it>copies. The <it>SMN1 </it>gene produces a full-length transcript (FL-SMN) while <it>SMN2 </it>is only able to produce a small portion of the FL-SMN because of a splice mutation which results in the production of abnormal SMNΞ”7 mRNA.</p> <p>Methods</p> <p>In this study we performed quantification of the <it>SMN2 </it>gene copy number in Russian patients affected by SMA type II and III (42 and 19 patients, respectively) by means of real-time PCR. Moreover, we present two families consisting of asymptomatic carriers of a homozygous absence of the <it>SMN1 </it>gene. We also developed a novel RT-qPCR-based assay to determine the FL-SMN/SMNΞ”7 mRNA ratio as SMA biomarker.</p> <p>Results</p> <p>Comparison of the <it>SMN2 </it>copy number and clinical features revealed a significant correlation between mild clinical phenotype (SMA type III) and presence of four copies of the <it>SMN2 </it>gene. In both asymptomatic cases we found an increased number of <it>SMN2 </it>copies in the healthy carriers and a biallelic <it>SMN1 </it>absence. Furthermore, the novel assay revealed a difference between SMA patients and healthy controls.</p> <p>Conclusions</p> <p>We suggest that the <it>SMN2 </it>gene copy quantification in SMA patients could be used as a prognostic tool for discrimination between the SMA type II and SMA type III diagnoses, whereas the FL-SMN/SMNΞ”7 mRNA ratio could be a useful biomarker for detecting changes during SMA pharmacotherapy.</p

    Π‘ΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΎΠΏΠ»Π°Ρ‚Ρ‹ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ хроничСском вирусном Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚Π΅ Π‘ Π² Ρ€Π°ΠΌΠΊΠ°Ρ… Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠŸΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ государствСнных Π³Π°Ρ€Π°Π½Ρ‚ΠΈΠΉ бСсплатного оказания Π³Ρ€Π°ΠΆΠ΄Π°Π½Π°ΠΌ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π½Π° 2023 Π³ΠΎΠ΄ ΠΈ Π½Π° ΠΏΠ»Π°Π½ΠΎΠ²Ρ‹ΠΉ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ 2024–2025 Π³ΠΎΠ΄ΠΎΠ²

    Get PDF
    Background. In 2021, new clinical guidelines for the treatment of chronic hepatitis C virus (HCV) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic HCV is based on modern drugs of direct-acting antivirals (DAA). In this regard, the model of diagnosis-related groups (DRG) with the use of interferon-containing drugs as etiotropic therapy, which has been in effect until now, has lost its relevance and cannot be used to pay for cases of medical care for chronic HCV within the framework of the Program of State Guarantees of Free Medical Care to Citizens for 2023 and for the planning period of 2024–2025 (PSG). Objective: to improve the DRG model to pay for medical care for chronic HCV in a day hospital based on current clinical recommendations.Material and methods. Regulatory legal documents on the subject of the study, proposals and expert opinions of specialists, as well as feedback from public organizations, including patients, regarding the payment of medical care for chronic HCV, sent as part of a public discussion of the draft PSG, were studied. For the calculations were used: the current version of the clinical recommendations "Chronic viral hepatitis C"; impersonal personalized information of the database of registers of bills for payment for medical care for 2020–2021; the state register of manufacturers' maximum selling prices for medicines included in the list of vital and essential drugs.Results. A DRG model was developed to pay for medical care during drug therapy of chronic HCV, including for children. When calculating the model, the cost of medicines, patient days and the principles of accounting for the duration of hospitalization were updated.Conclusion. The developed DRG model to pay for medical care for chronic HCV in a day hospital with the use of drug therapy regimens with DAA recommended by clinical guidelines, including for children with HCV, contributes to improving the effectiveness of the system of payment for medical care provided as part of the implementation of the PSG and accessibility of medical care for this contingent of patients.ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Π’ 2021 Π³. ΠΎΠΏΡƒΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½Ρ‹ Π½ΠΎΠ²Ρ‹Π΅ клиничСскиС Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†ΠΈΠΈ ΠΏΠΎ Π»Π΅Ρ‡Π΅Π½ΠΈΡŽ хроничСского вирусного Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚Π° Π‘ (Π₯Π’Π“Π‘) Ρƒ взрослых, Π² ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… ΠΎΡ‚ΡΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‚ ΠΈΠ½Ρ‚Π΅Ρ€Ρ„Π΅Ρ€ΠΎΠ½ΠΎΠ²Ρ‹Π΅ схСмы лСкарствСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Π°Ρ тСрапия Π₯Π’Π“Π‘ базируСтся Π½Π° соврСмСнных противовирусных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°Ρ… прямого дСйствия (ΠŸΠŸΠŸΠ”). Π’ этой связи модСль ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-статистичСских Π³Ρ€ΡƒΠΏΠΏ (ΠšΠ‘Π“) с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ Π² качСствС этиотропной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ интСрфСроносодСрТащих ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², Π΄Π΅ΠΉΡΡ‚Π²ΡƒΡŽΡ‰Π°Ρ Π΄ΠΎ настоящСго Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ, ΡƒΡ‚Ρ€Π°Ρ‚ΠΈΠ»Π° Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ ΠΈ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ‚ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Ρ‚ΡŒΡΡ для ΠΎΠΏΠ»Π°Ρ‚Ρ‹ случаСв оказания мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ Π₯Π’Π“Π‘ Π² Ρ€Π°ΠΌΠΊΠ°Ρ… Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠŸΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ государствСнных Π³Π°Ρ€Π°Π½Ρ‚ΠΈΠΉ бСсплатного оказания Π³Ρ€Π°ΠΆΠ΄Π°Π½Π°ΠΌ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π½Π° 2023 Π³ΠΎΠ΄ ΠΈ Π½Π° ΠΏΠ»Π°Π½ΠΎΠ²Ρ‹ΠΉ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ 2024–2025 Π³ΠΎΠ΄ΠΎΠ² (ΠŸΠ“Π“).ЦСль: ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠšΠ‘Π“ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ для ΠΎΠΏΠ»Π°Ρ‚Ρ‹ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ Π₯Π’Π“Π‘ Π² условиях Π΄Π½Π΅Π²Π½ΠΎΠ³ΠΎ стационара Π½Π° основС Π΄Π΅ΠΉΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… клиничСских Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†ΠΈΠΉ.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π˜Π·ΡƒΡ‡Π΅Π½Ρ‹ Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½Ρ‹Π΅ ΠΏΡ€Π°Π²ΠΎΠ²Ρ‹Π΅ Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Ρ‹ ΠΏΠΎ Ρ‚Π΅ΠΌΠ΅ исслСдования, прСдлоТСния ΠΈ экспСртныС мнСния спСциалистов, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΎΡ‚Π·Ρ‹Π²Ρ‹ общСствСнных ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΉ, Π²ΠΊΠ»ΡŽΡ‡Π°Ρ пациСнтскиС, Π² части ΠΎΠΏΠ»Π°Ρ‚Ρ‹ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ Π₯Π’Π“Π‘, Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½Ρ‹Π΅ Π² Ρ€Π°ΠΌΠΊΠ°Ρ… общСствСнного обсуТдСния ΠΏΡ€ΠΎΠ΅ΠΊΡ‚Π° ΠŸΠ“Π“. Для провСдСния расчСтов использовались: Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Π°Ρ вСрсия клиничСских Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†ΠΈΠΉ Β«Π₯роничСский вирусный Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚ Π‘Β», ΠΎΠ±Π΅Π·Π»ΠΈΡ‡Π΅Π½Π½Ρ‹Π΅ пСрсонифицированныС свСдСния Π±Π°Π·Ρ‹ рССстров счСтов Π½Π° ΠΎΠΏΠ»Π°Ρ‚Ρƒ Π·Π° ΠΎΠΊΠ°Π·Π°Π½ΠΈΠ΅ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π·Π° 2020–2021 Π³Π³., государствСнный рССстр ΠΏΡ€Π΅Π΄Π΅Π»ΡŒΠ½Ρ‹Ρ… отпускных Ρ†Π΅Π½ ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»Π΅ΠΉ Π½Π° лСкарствСнныС ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Ρ‹, Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Π½Ρ‹Π΅ Π² ΠΏΠ΅Ρ€Π΅Ρ‡Π΅Π½ΡŒ ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΡ‹Ρ… ΠΈ Π²Π°ΠΆΠ½Π΅ΠΉΡˆΠΈΡ… лСкарствСнных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ².Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π° модСль ΠšΠ‘Π“ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ для ΠΎΠΏΠ»Π°Ρ‚Ρ‹ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ лСкарствСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π₯Π’Π“Π‘, Π² Ρ‚.Ρ‡. для ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² дСтского возраста. ΠŸΡ€ΠΈ расчСтС ΠΌΠΎΠ΄Π΅Π»ΠΈ Π°ΠΊΡ‚ΡƒΠ°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Π° ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎ-дня ΠΈ ΠΏΡ€ΠΈΠ½Ρ†ΠΈΠΏΡ‹ ΡƒΡ‡Π΅Ρ‚Π° Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ госпитализации.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Разработанная модСль ΠšΠ‘Π“ для ΠΎΠΏΠ»Π°Ρ‚Ρ‹ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ Π₯Π’Π“Π‘ Π² условиях Π΄Π½Π΅Π²Π½ΠΎΠ³ΠΎ стационара с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ схСм лСкарствСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠŸΠŸΠŸΠ”, ΠΏΡ€Π΅Π΄Π»Π°Π³Π°Π΅ΠΌΡ‹Ρ… клиничСскими рСкомСндациями, Π² Ρ‚.Ρ‡. для Π΄Π΅Ρ‚Π΅ΠΉ с Π₯Π’Π“Π‘, способствуСт ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡŽ эффСктивности систСмы ΠΎΠΏΠ»Π°Ρ‚Ρ‹ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ, ΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅ΠΌΠΎΠΉ Π² Ρ€Π°ΠΌΠΊΠ°Ρ… Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠŸΠ“Π“, ΠΈ доступности мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ для Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΊΠΎΠ½Ρ‚ΠΈΠ½Π³Π΅Π½Ρ‚Π° Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…
    corecore